Document is current
Any future updates will be listed below
-
Authors
Osadchiy, Vadim https://orcid.org/0000-0003-0492-9987
Mayer, Emeran A.
Gao, Kan
Labus, Jennifer S.
Naliboff, Bruce
Tillisch, Kirsten https://orcid.org/0000-0001-6630-5745
Chang, Lin
Jacobs, Jonathan P.
Hsiao, Elaine Y.
Gupta, Arpana https://orcid.org/0000-0002-1669-9624
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (ULTR001881/DK041301, P50 DK064539, R01 DK048351)
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (K23 DK106528, P50 DK064539, R01 DK048351)
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
- License Information
-
More Information
Article History
Received: 2 August 2020
Revised: 11 September 2020
Accepted: 5 October 2020
First Online: 2 November 2020
Conflict of interest
: E.A.M. is a scientific advisory board member of Danone, Axial Biotherapeutics, Viome, Amare, Mahana Therapeutics, UBiome, Pendulum, Bloom Biosciences, APC Microbiome Ireland. V.O., K.G., J.S.L., B.N., K.T., L.C., J.P.J., E.Y.H., and A.G. have nothing to disclose.
